Matsko De
26 Papers
379 Citations
Matsko De is an academic researcher. The author has contributed to research in topics: Breast cancer & Germline mutation. The author has an hindex of 12, co-authored 26 publications.
Chat about Author
Papers
High frequency of BRCA1 5382insC mutation in Russian breast cancer patients
Anna P. Sokolenko,Natalia V. Mitiushkina,Konstantin G. Buslov,Elena M. Bit-Sava,Aglaya G. Iyevleva,Elena V. Chekmariova,Ekatherina Sh. Kuligina,Yulia M. Ulibina,Maxim E. Rozanov,Evgeny N. Suspitsin,Matsko De,Oleg L. Chagunava,Dmitry Yu. Trofimov,Peter Devilee,Cees J. Cornelisse,Alexandr V. Togo,Vladimir Semiglazov,Evgeny N. Imyanitov +17 more
TL;DR: Evaluated data confirm a noticeable contribution of BRCA1 5382insC mutation in BC development in Russia, that may justify an extended BRC a 5382inC testing within this population, and confirm none of 478 middle-aged controls and 344 elderly tumour-free women carried the 5382 insC variant.
82
High prevalence and breast cancer predisposing role of the BLM c.1642 C>T (Q548X) mutation in Russia
Anna P. Sokolenko,Aglaya G. Iyevleva,Elena V. Preobrazhenskaya,Nathalia V. Mitiushkina,Svetlana N. Abysheva,Evgeny N. Suspitsin,Ekatherina Sh. Kuligina,Tatiana V. Gorodnova,Werner Pfeifer,Alexandr V. Togo,Turkevich Ea,Alexandr O. Ivantsov,Dmitry V Voskresenskiy,Georgy D Dolmatov,Elena M. Bit-Sava,Matsko De,Vladimir Semiglazov,Iduna Fichtner,Alexey Larionov,Sergey G. Kuznetsov,Antonis C. Antoniou,Evgeny N. Imyanitov +21 more
TL;DR: It is demonstrated that BLM Q548X allele is recurrent in Slavic subjects and may be associated with BC risk and the BLM‐associated BC exhibited somatic loss of heterozygosity at the BLM gene locus.
68
NBS1 657del5 mutation may contribute only to a limited fraction of breast cancer cases in Russia.
Konstantin G. Buslov,Aglaya G. Iyevleva,Elena V. Chekmariova,Evgeny N. Suspitsin,Alexandr V. Togo,Ekatherina Sh. Kuligina,Anna P. Sokolenko,Matsko De,Turkevich Ea,Yulia R. Lazareva,Oleg L. Chagunava,Elena M. Bit-Sava,Vladimir Semiglazov,Peter Devilee,Cees J. Cornelisse,Kaido P. Hanson,Evgeny N. Imyanitov +16 more
TL;DR: Overall, the data suggest that the NBS1 657del5 allele may contribute only to a limited fraction of breast cancer cases in Russia.
67
Detection of EGFR mutations and EML4-ALK rearrangements in lung adenocarcinomas using archived cytological slides.
Natalia V. Mitiushkina,Aglaya G. Iyevleva,A. Poltoratskiy,Alexandr O. Ivantsov,Alexandr V. Togo,Igor S. Polyakov,Sergey V. Orlov,Matsko De,Viktor I. Novik,Evgeny N. Imyanitov +9 more
TL;DR: Although the molecular analysis of epidermal growth factor receptor (EGFR) and anaplastic lymphoma kinase) in archived lung cancer tissues is relatively well established, the genetic testing of cytological material has not yet become a routine.
51
High efficacy of first-line gefitinib in non-Asian patients with EGFR-mutated lung adenocarcinoma.
Vladimir M. Moiseyenko,Svetlana A. Procenko,Evgeny Levchenko,Barchuk As,Fedor V. Moiseyenko,Aglaya G. Iyevleva,Nathalia V. Mitiushkina,Alexandr V. Togo,Igor I. Semionov,Alexandr O. Ivantsov,Matsko De,Evgeny N. Imyanitov +11 more
TL;DR: Gefitinib may be considered as an upfront treatment option for EGFR-mutated NSCLC after feasibility of front-line administration of this EGFR tyrosine kinase inhibitor in non-Asian subjects was demonstrated.
44